Oral fluids as an alternative to serum for measurement of markers of immune activation

被引:61
作者
Nishanian, P [1 ]
Aziz, N
Chung, J
Detels, R
Fahey, JL
机构
[1] Univ Calif Los Angeles, Sch Med, CIRID, Dept Microbiol & Immunol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA
关键词
D O I
10.1128/CDLI.5.4.507-512.1998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Oral fluids are convenient alternatives to blood sampling for evaluating significant metabolic components. Two forms of oral fluids, oral mucosal transudates (OMT) and saliva, were collected and compared for content of soluble products of immune activation. The data confirm that OMT and saliva represent distinct body fluids. The concentrations, outputs, and analyte/protein ratios of beta-2-microglobulin (beta 2M), soluble tumor necrosis factor alpha receptor II (sTNF alpha RII), and neopterin were measured. Both the OMT and the saliva of most of the individuals in the control healthy populations had measurable levels of all three activation markers. When the immune system is activated, as in human immunodeficiency virus (HIV) infection, the levels of beta 2M and sTNF alpha RII are increased in both OMT and saliva compared to those in a healthy control population. OMT levels correlated better with levels in serum than did saliva and appear to reflect systemic immune activation in HIV infection. Because acquisition of oral fluids is noninvasive and easily repeatable, measurement of beta 2M and/or sTNF alpha RII content in OMT could be useful in the assessment of disease activity in patients with HIV infection or chronic inflammatory diseases.
引用
收藏
页码:507 / 512
页数:6
相关论文
共 33 条
[1]  
Akalin F. Alev, 1993, Journal of Nihon University School of Dentistry, V35, P230
[2]  
AUFRICHT C, 1992, EUR J CLIN CHEM CLIN, V30, P81
[3]   SERUM LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) AND SOLUBLE TNF RECEPTORS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - CORRELATIONS TO CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL PARAMETERS [J].
AUKRUST, P ;
LIABAKK, NB ;
MULLER, F ;
LIEN, E ;
ESPEVIK, T ;
FROLAND, SS .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) :420-424
[4]   THE DIAGNOSIS VALUE OF BETA-2-MICROGLOBULIN AND IMMUNOGLOBULINS IN PRIMARY SJOGRENS-SYNDROME [J].
BONGI, SM ;
CAMPANA, G ;
DAGATA, A ;
PALERMO, C ;
BIANUCCI, G .
CLINICAL RHEUMATOLOGY, 1995, 14 (02) :151-156
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   SOLUBLE RECEPTORS FOR TUMOR-NECROSIS-FACTOR IN CLINICAL LABORATORY DIAGNOSIS [J].
DIEZRUIZ, A ;
TILZ, GP ;
ZANGERLE, R ;
BAIERBITTERLICH, G ;
WACHTER, H ;
FUCHS, D .
EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 54 (01) :1-8
[7]   THE EFFECT OF INCREASED MASTICATION BY DAILY GUM-CHEWING ON SALIVARY-GLAND OUTPUT AND DENTAL PLAQUE ACIDOGENICITY [J].
DODDS, MWJ ;
HSIEH, SC ;
JOHNSON, DA .
JOURNAL OF DENTAL RESEARCH, 1991, 70 (12) :1474-1478
[8]  
EVANS MRW, 1995, CLIN CHEM, V41, P950
[9]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172
[10]  
FERGUSON DB, 1984, STEROID HORMONES SAL